AIM To identify patients with or without liver steatosisand its severity in treatment-na?ve patients affected byhepatitis C virus (HCV) infection.METHODS: We includ
AIM To evaluate risk of recidivism on a case-by-case basis.METHODS From our center’s liver transplant program,we selected patients with alcoholic liver disease
AIM: To study the interleukin-1(IL-1) pathway as a therapeutic target for liver fibrosis in vitro and in vivo using the ATP-binding cassette transporter b4-/-(Abc